Fund Evaluator:
Spear Alpha ETF (SPRX)
Follow This Fund
Equity
Global Asset Class
Sector Equity
Fund Group
Technology
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.75% D
Expense Ratio
$206 Mil
Assets
Open
Status
0.00%
12b-1 Fee
0.00%
TTM Yield
0.00%
Max Load
na
Portfolio Turnover
Best Performing in Technology Over the Last Year
| 98.0% | Fidelity Select Tech Hardware (FDCPX) |
| 94.3% | Rydex Electronics Inv (RYSIX) |
| 84.8% | Fidelity Advisor Semiconductors Z (FIKGX) |
| 84.6% | Fidelity Advisor Semiconductors I (FELIX) |
| 83.4% | Berkshire Focus (BFOCX) |
Data as of 7/31/2026
-26.5% F
1-Mo Return
-1.2% F
3-Mo Return
10.8% D
YTD Return
28.2% C
1-Yr Return
29.2% A
3-Yr Return
na
5-Yr Return
1.54 F
Category Risk Index
3.34
Total Risk Index
Fund Details
Fund Family
Spear
Inception Date
8/3/2021
Share Class Type
Equity Investment Style
Mid-Cap
Growth
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
S&P 500 (TR) (1970): 100%
Additional Fund Details
Spear Alpha ETF Overview
SPRX Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| SPRX Return (NAV) | -26.5% | -1.2% | 28.2% | 29.2% | na | na |
| SPRX Grade | F | F | C | A | na | na |
| +/- Category | -17.9% | -8.0% | -6.4% | 2.4% | na | na |
| Technology Avg | -8.6% | 6.8% | 34.7% | 26.9% | 12.7% | 20.8% |
| SPRX Tax Cost Ratio | na | na | 0.0% | 0.0% | na | na |
SPRX Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| SPRX Return (NAV) | 10.8% | 42.1% | 20.6% | 87.6% | -44.8% | na | na | na | na | na | na |
| SPRX Grade | D | A | C | A | F | na | na | na | na | na | na |
| +/- Category | -10.6% | 17.4% | -7.7% | 38.0% | -6.6% | na | na | na | na | na | na |
| Technology Avg | 21.4% | 24.7% | 28.3% | 49.6% | -38.2% | 17.2% | 56.9% | 41.2% | -3.9% | 37.4% | 10.8% |
| Risk Measures | |
| Standard Deviation: | 41.0% |
| Total Risk Index: | 3.34 - High |
| Category Risk Index: | 1.54 - High |
| Category Risk Grade: | F (98% Rank) |
| Beta: | 2.31 |
| R-Squared: | 51% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Mid-Cap Growth |
| Bond Investment Style: | na |
| Yield: | 0.0% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | |
| Total Assets: | $206 Mil |
| Fund Total Assets: | $ 207 Mil |
| Share Class Type: | |
| Portfolio Turnover: | na |
Management Team
| Number of Managers: 1 | |||
| Longest Tenure: 5.0 years | |||
| Average Tenure: 5.0 years | |||
| Managers (Year): Delevska Ivana (2021) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 29 |
| % in Top 10 Holdings: | 74.6% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 5.1% |
Portfolio Allocation |
|
| Domestic Stock: | 95.0% |
| Foreign Stock: | 5.1% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 1.0% |
| Cash: | -1.0% |
Purchase Information
| Fund Family: | Spear |
| Phone Number: | 800-617-0004 |
| Website: |
| Status: | Open |
| Inception Date: | August 3, 2021 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.00% |
Expenses and Fees | |
| Expense Ratio (%): | 0.75% ( Rating : Above Avg ) |
| Category Average Expense Ratio (%): | 1.23% |
| Share Class: | Spear Alpha ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.